Fig. 2From: Pharmacokinetic/Pharmacodynamic modelling of Saxagliptin and its active metabolite, 5-hydroxy Saxagliptin in rats with Type 2 Diabetes MellitusSchematic representation of the PK/PD model of 5-OH SAX in T2DM ratsBack to article page
